MicroRNA 106a is a protein that in humans is encoded by the MIR106A gene.
[1]
Function
microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009].
Hackl M, Brunner S, Fortschegger K, Schreiner C, Micutkova L, Mück C, Laschober GT, Lepperdinger G, Sampson N, Berger P, Herndler-Brandstetter D, Wieser M, Kühnel H, Strasser A, Rinnerthaler M, Breitenbach M, Mildner M, Eckhart L, Tschachler E, Trost A, Bauer JW, Papak C, Trajanoski Z, Scheideler M, Grillari-Voglauer R, Grubeck-Loebenstein B, Jansen-Dürr P, Grillari J (2010). "miR-17, miR-19b, miR-20a, and miR-106a are down-regulated in human aging". Aging Cell. 9 (2): 291–6. doi:10.1111/j.1474-9726.2010.00549.x. PMC2848978. PMID20089119.
Zhou H, Guo JM, Lou YR, Zhang XJ, Zhong FD, Jiang Z, Cheng J, Xiao BX (2010). "Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker". J. Mol. Med. 88 (7): 709–17. doi:10.1007/s00109-010-0617-2. PMID20349219.
Hummel R, Hussey DJ, Michael MZ, Haier J, Bruewer M, Senninger N, Watson DI (2011). "MiRNAs and their association with locoregional staging and survival following surgery for esophageal carcinoma". Ann. Surg. Oncol. 18 (1): 253–60. doi:10.1245/s10434-010-1213-y. PMID20628822.
Jiang X, Li N (2011). "Induction of MiR-17-3p and MiR-106a [corrected] by TNFα and LPS". Cell Biochem. Funct. 29 (2): 164–70. doi:10.1002/cbf.1728. PMID21370248.
Yang G, Zhang R, Chen X, Mu Y, Ai J, Shi C, Liu Y, Shi C, Sun L, Rainov NG, Li H, Yang B, Zhao S (2011). "MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status". J. Mol. Med. 89 (10): 1037–50. doi:10.1007/s00109-011-0775-x. PMID21656380.
Wang Z, Liu M, Zhu H, Zhang W, He S, Hu C, Quan L, Bai J, Xu N (2013). "miR-106a is frequently upregulated in gastric cancer and inhibits the extrinsic apoptotic pathway by targeting FAS". Mol. Carcinog. 52 (8): 634–46. doi:10.1002/mc.21899. PMID22431000.